Connor, Clark & Lunn Investment Management (CC&L)
RPRX icon

Connor, Clark & Lunn Investment Management (CC&L)’s Royalty Pharma RPRX Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio RPRX Stock Details RPRX Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$626K Buy
+17,366
New +$626K ﹤0.01% 1189
2022
Q4 		– Sell
-39,873
Closed -$1.6M – 1397
2022
Q3 		$1.6M Buy
39,873
+24,128
+153% +$969K 0.01% 544
2022
Q2 		$662K Buy
+15,745
New +$662K ﹤0.01% 713